[go: up one dir, main page]

IL158754A0 - Removal of plasmin(ogen) from protein solutions - Google Patents

Removal of plasmin(ogen) from protein solutions

Info

Publication number
IL158754A0
IL158754A0 IL15875402A IL15875402A IL158754A0 IL 158754 A0 IL158754 A0 IL 158754A0 IL 15875402 A IL15875402 A IL 15875402A IL 15875402 A IL15875402 A IL 15875402A IL 158754 A0 IL158754 A0 IL 158754A0
Authority
IL
Israel
Prior art keywords
plasmin
ogen
amino acid
removal
protein solutions
Prior art date
Application number
IL15875402A
Other languages
English (en)
Original Assignee
Omrix Biopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omrix Biopharm Sa filed Critical Omrix Biopharm Sa
Publication of IL158754A0 publication Critical patent/IL158754A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
IL15875402A 2001-05-21 2002-05-17 Removal of plasmin(ogen) from protein solutions IL158754A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29196801P 2001-05-21 2001-05-21
EP01115157 2001-06-21
PCT/EP2002/005462 WO2002095019A1 (en) 2001-05-21 2002-05-17 Removal of plasmin(ogen) from protein solutions

Publications (1)

Publication Number Publication Date
IL158754A0 true IL158754A0 (en) 2004-05-12

Family

ID=26076623

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15875402A IL158754A0 (en) 2001-05-21 2002-05-17 Removal of plasmin(ogen) from protein solutions
IL158754A IL158754A (en) 2001-05-21 2003-11-05 Removal of plasmin (flange) from protein solutions

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158754A IL158754A (en) 2001-05-21 2003-11-05 Removal of plasmin (flange) from protein solutions

Country Status (20)

Country Link
US (4) US20040197891A1 (pl)
EP (1) EP1390485B1 (pl)
JP (1) JP4385097B2 (pl)
KR (1) KR100871454B1 (pl)
AT (1) ATE342353T1 (pl)
AU (1) AU2002314081B2 (pl)
CA (1) CA2447789C (pl)
CZ (1) CZ20033097A3 (pl)
DE (1) DE60215338T2 (pl)
EE (1) EE05485B1 (pl)
ES (1) ES2274044T3 (pl)
HK (1) HK1060902A1 (pl)
HU (1) HU228899B1 (pl)
IL (2) IL158754A0 (pl)
MX (1) MXPA03010616A (pl)
PL (1) PL205685B1 (pl)
RU (2) RU2458067C2 (pl)
SK (1) SK288005B6 (pl)
WO (1) WO2002095019A1 (pl)
ZA (1) ZA200309030B (pl)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL205685B1 (pl) 2001-05-21 2010-05-31 Omrix Biopharm Sa Sposób in vitro usuwania lub wyodrębniania plazminogenu lub plazminy w obecności fibrynogenu, stałe podłoże powinowactwa do oczyszczania mieszaniny zawierającej fibrynogen i plazminę i/lub plazminogen oraz krioprecypitat
SE526038C2 (sv) * 2002-07-08 2005-06-21 Gambro Lundia Ab Polymeraffinitetsmatris, förfarande för framställning därav och anvädning därav
CA2514474C (en) 2003-01-30 2014-05-06 Avner Yayon Freeze-dried fibrin matrices and methods for preparation thereof
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
DE102004009400A1 (de) 2004-02-24 2005-09-08 Zlb Behring Gmbh Fibrinogen Reinigung
US7335508B2 (en) 2004-07-22 2008-02-26 Prochon Biotech Ltd. Porous plasma protein matrices and methods for preparation thereof
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
EP2052746B1 (en) 2004-10-20 2014-11-26 Ethicon, Inc. Absorbable hemostat
US9358318B2 (en) 2004-10-20 2016-06-07 Ethicon, Inc. Method of making a reinforced absorbable multilayered hemostatic wound dressing
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP2007068497A (ja) * 2005-09-09 2007-03-22 Nihon Pharmaceutical Co Ltd プラスミンの精製法
US8921109B2 (en) 2005-09-19 2014-12-30 Histogenics Corporation Cell-support matrix having narrowly defined uniformly vertically and non-randomly organized porosity and pore density and a method for preparation thereof
US20070134231A1 (en) * 2005-12-13 2007-06-14 Jani Dharmendra M Method for prolonging activity of autodegradable enzymes and compositions thereof
BRPI0718145B8 (pt) 2006-11-02 2021-05-25 Omrix Biopharmaceuticals Ltd método de micronização
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US8409499B2 (en) 2007-06-07 2013-04-02 Ethicon, Inc. Method for establishing a sterilizing dose for radiation sensitive products
US7704453B2 (en) 2007-06-07 2010-04-27 Ethicon, Inc. Method for establishing a sterilizing dose for radiation sensitive products
EP2011524A1 (en) * 2007-07-02 2009-01-07 Omrix Biopharmaceuticals Ltd. Fibrin glue with a visualization agent
EP2034010A1 (en) 2007-08-30 2009-03-11 Omrix Biopharmaceuticals Ltd. Compositions suitable for repair and/or treatment of injured spinal tissue
CA2717725A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
EP2331158B1 (en) 2008-09-22 2013-09-11 Omrix Biopharmaceuticals Ltd. Implantable device comprising a substrate pre-coated with stabilized fibrin
EP2398394B1 (en) * 2009-02-20 2021-08-04 Omrix Biopharmaceuticals Ltd. Device for administering an at least two-component substance
CN102791299B (zh) 2010-01-28 2014-10-22 奥姆里克斯生物药品有限公司 具有改善的密封特性的纤维蛋白基质及其制备和用途
WO2011146179A2 (en) * 2010-05-18 2011-11-24 Abbott Laboratories Apparatus and process of purification of proteins
IL207586A0 (en) * 2010-08-12 2010-12-30 Omrix Biopharmaceuticals Ltd A fibrin based therapeutic preparation and use thereof
JP5836577B2 (ja) * 2010-09-14 2015-12-24 株式会社カネカ クリングル配列を有する蛋白質またはペプチドを精製または除去するアフィニティ担体の製造方法、その精製方法、除去方法
WO2012036140A1 (ja) * 2010-09-14 2012-03-22 株式会社カネカ クリングル配列を有する蛋白質またはペプチドを精製または除去するアフィニティ担体、及びそれを用いた精製方法、除去方法
CN106046147B (zh) * 2010-09-20 2019-11-19 欧克塔医药公司 纤维蛋白原生产方法
IL210162A0 (en) 2010-12-21 2011-03-31 Omrix Biopharmaceuticals Viral inactivated platelet extract, use and preparation thereof
IL213375A0 (en) 2011-06-05 2011-07-31 Omrix Biopharmaceuticals Device for spraying fluids in proximity to a surface
EP2723354B3 (en) 2011-06-27 2021-03-24 Emory University Compositions, uses, and preparation of platelet lysates
IL213864A0 (en) 2011-06-30 2011-08-31 Omrix Biopharmaceuticals Ltd Method for removing a lytic enzyme from a heterogeneous mixture
RU2605710C2 (ru) 2011-12-29 2016-12-27 Омрикс Биофармасьютикалс Лтд. Способ и устройство для быстрого растворения твердой белковой композиции
US10130346B2 (en) 2012-07-24 2018-11-20 Omrix Biopharmaceuticals Ltd. Device and method for the application of a curable fluid composition to a bodily organ
US20140154233A1 (en) * 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
CN104994886B (zh) 2012-12-20 2017-10-03 奥姆里克斯生物药品有限公司 病毒灭活的生物混合物
CA2896760A1 (en) 2012-12-30 2014-07-03 Omrix Biopharmaceuticals Ltd. Device and method for the application of a curable fluid composition to a portion of a bodily organ
USD754325S1 (en) 2013-06-06 2016-04-19 Omrix Biopharmaceuticals Ltd. Device of a curable fluid composition to a bodily organ
IL230151A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
IL230150A0 (en) 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing zymogens
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
IL234246A0 (en) 2014-08-21 2014-11-30 Omrix Biopharmaceuticals Ltd Stabilized thrombin
IL235751A0 (en) 2014-11-18 2015-02-26 Omrix Biopharmaceuticals Ltd An addition to the spray dryer
WO2016079727A1 (en) 2014-11-18 2016-05-26 Omrix Biopharmaceuticals Ltd. Spray-drying apparatus and method of use
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
WO2016132357A1 (en) 2015-02-16 2016-08-25 Nayacure Therapeutics Ltd. Modified blood clots
CA2976875A1 (en) 2015-02-25 2016-09-01 Omrix Biopharmaceuticals Ltd. Method for purifying and quantifying thrombin and its degradation polypeptides
IL242984A0 (en) 2015-12-08 2016-02-29 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, their preparation and how to use them
US10159720B2 (en) 2015-12-08 2018-12-25 Omrix Biopharmaceuticals Ltd Thrombin microcapsules, preparation and uses thereof
EP3373986A1 (en) 2015-11-11 2018-09-19 Ethicon, Inc. Sealant formulation and uses thereof
IL242924A0 (en) 2015-12-03 2016-04-21 Omrix Biopharmaceuticals Ltd Syringe system for storing and mixing two ingredients
IL265102B2 (en) * 2016-09-01 2023-11-01 Plas Free Ltd Human Blood-Derived Products Having Decreased Fibrinolytic Activity And Uses Thereof In Hemostatic Disorders
IT201600091964A1 (it) 2016-09-13 2018-03-13 Kedrion Spa Processo per la purificazione del plasminogeno a partire da plasma umano.
IL247821A0 (en) * 2016-09-14 2017-01-31 Omrix Biopharmaceuticals Ltd Adhesive preparations and their use
JP7269184B2 (ja) * 2017-03-09 2023-05-08 プリビファーマ・コンサルティング・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 血液画分からのＧｌｕ－プラスミノーゲンの製造および使用
IL256405A (en) 2017-12-19 2018-01-31 Omrix Biopharmaceuticals Ltd Wound bandage and method for its production
ES2983341T3 (es) * 2018-02-28 2024-10-22 Plas Free Ltd Dispositivo extracorpóreo y matriz para la eliminación de proteínas fibrinolíticas de fluidos biológicos, métodos y usos de los mismos
WO2020121290A1 (en) 2018-12-12 2020-06-18 Omrix Biopharmaceuticals Ltd. High concentrated protein compositions for preventing tissue adhesion
IL263679A (en) 2018-12-12 2019-03-31 Omrix Biopharmaceuticals Ltd Kits, methods, and compositions for preventing tissue adhesion
CN111760556B (zh) * 2020-07-09 2023-06-30 江苏尤里卡生物科技有限公司 一种尿激酶吸附剂及其制备方法和应用
WO2022099223A2 (en) 2020-11-09 2022-05-12 Takeda Pharmaceutical Company Limited Purification of fviii from plasma using silicon oxide adsorption
CN117460823A (zh) 2021-06-08 2024-01-26 先觉药业咨询公司 从血浆级分中分离纤溶酶原的方法
CN113533594A (zh) * 2021-06-30 2021-10-22 长沙都正生物科技股份有限公司 用于测定氨甲环酸含量的方法及试剂盒
US20230085152A1 (en) 2021-09-16 2023-03-16 Ethicon, Inc. Kit for Composition for Tissue Tract Sealing
US20250073313A1 (en) 2021-12-21 2025-03-06 Omrix Biopharmaceuticals Ltd. Highly soluble fibrinogen compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3943245A (en) * 1974-02-14 1976-03-09 Armour Pharmaceutical Company Purification of plasminogen
SU979508A1 (ru) * 1980-07-23 1982-12-07 Ордена Трудового Красного Знамени Институт Биохимии Им.А.В.Палладина Способ получени иммобилизованного плазминогена
US4639513A (en) * 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
US4639543A (en) 1985-02-04 1987-01-27 Richard J. Birch Semiconductor devices having a metallic glass substrate
JPS6391080A (ja) 1986-10-03 1988-04-21 Kanegafuchi Chem Ind Co Ltd ヒト組織プラスミノゲン活性化因子の精製法
GB8902771D0 (en) * 1989-02-08 1989-03-30 Bioprocessing Ltd Improvements in or relating to affinity chromatography
ATE197067T1 (de) 1989-04-07 2000-11-15 Cancerforskningsfonden Af 1989 Plasminogen-aktivator-rezeptor vom urokinasetyp
SU1727839A1 (ru) 1990-05-30 1992-04-23 МГУ им.М.В.Ломоносова Способ получени фибриногена
US5792835A (en) * 1991-09-05 1998-08-11 Baxter International Inc. Method of preparing a topical fibrinogen complex
DK82592D0 (da) * 1992-06-23 1992-06-23 Novo Nordisk As Fremstilling af proteiner
US5362859A (en) 1992-07-27 1994-11-08 Sepracor, Inc. High-capacity affinity supports and methods for the preparation and use of same
JPH08225461A (ja) 1995-02-21 1996-09-03 Green Cross Corp:The プラスミノーゲンの精製方法およびプラスミノーゲン製剤
JP3763598B2 (ja) 1995-09-11 2006-04-05 旭電化工業株式会社 トラネキサム酸の製造方法
US6451978B2 (en) * 2000-01-21 2002-09-17 Biovitrum Ab Purification of antithrombin-III-α and β
PL205685B1 (pl) * 2001-05-21 2010-05-31 Omrix Biopharm Sa Sposób in vitro usuwania lub wyodrębniania plazminogenu lub plazminy w obecności fibrynogenu, stałe podłoże powinowactwa do oczyszczania mieszaniny zawierającej fibrynogen i plazminę i/lub plazminogen oraz krioprecypitat

Also Published As

Publication number Publication date
KR100871454B1 (ko) 2008-12-03
HU228899B1 (en) 2013-06-28
DE60215338D1 (de) 2006-11-23
US8563288B2 (en) 2013-10-22
CA2447789C (en) 2012-11-06
PL205685B1 (pl) 2010-05-31
US20090176293A1 (en) 2009-07-09
RU2008130356A (ru) 2010-01-27
KR20040011503A (ko) 2004-02-05
US20030124703A1 (en) 2003-07-03
HUP0600110A2 (en) 2006-05-29
SK14202003A3 (sk) 2004-08-03
US20070092959A1 (en) 2007-04-26
US20040197891A1 (en) 2004-10-07
IL158754A (en) 2009-05-04
EP1390485A1 (en) 2004-02-25
ZA200309030B (en) 2005-06-29
CZ20033097A3 (cs) 2004-06-16
CA2447789A1 (en) 2002-11-28
JP4385097B2 (ja) 2009-12-16
EE200300578A (et) 2004-02-16
SK288005B6 (sk) 2012-10-02
HUP0600110A3 (en) 2010-01-28
WO2002095019A1 (en) 2002-11-28
ATE342353T1 (de) 2006-11-15
RU2344143C2 (ru) 2009-01-20
JP2004528853A (ja) 2004-09-24
RU2003136746A (ru) 2005-05-20
EE05485B1 (et) 2011-10-17
AU2002314081B2 (en) 2007-04-05
RU2458067C2 (ru) 2012-08-10
MXPA03010616A (es) 2004-04-02
EP1390485B1 (en) 2006-10-11
ES2274044T3 (es) 2007-05-16
US7641918B2 (en) 2010-01-05
US7125569B2 (en) 2006-10-24
PL365808A1 (pl) 2005-01-10
DE60215338T2 (de) 2007-05-16
HK1060902A1 (en) 2004-08-27

Similar Documents

Publication Publication Date Title
HK1060902A1 (en) Removal of plasmin (ogen) from protein solutions
EP1674477A3 (en) Binding polypeptides for B lymphocyte stimulator protein (BLYS)
BG102410A (en) Fine molecular inhibitors of rotamase enzymic activity
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
DE59409712D1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
WO2002074981A3 (en) Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase
IL150168A0 (en) Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods bsed thereon
SG149000A1 (en) Gag binding proteins
ATE154033T1 (de) Verfahren zur reinigung von proteinen
ATE273269T1 (de) Verfahren zur abtrennung von einer basischen aminosäure aus fermentationsbrühen
WO2002060917A3 (en) Method to treat hemophilia
NZ527971A (en) Nucleic acid molecules encoding a transmembrane serine protease 9, the encoded polypeptides and methods based thereon
ID21224A (id) Metode pembuatan obat yang mengandung protein plasma
AU2003260392A1 (en) Method for enriching a prokaryotic dna
ATE246692T1 (de) Verfahren zur reinigung von phosphatidylserin
DE69433875D1 (de) Verfahren zur präparation von humanem aktiviertem protein c
FR2814744B1 (fr) Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
ATE389010T1 (de) Verfahren zur herstellung von optisch aktiven pyridinethanol-derivaten
EP0776969A3 (de) Verfahren zur Herstellung von Proteinen durch kontrollierte proteolytische spaltung von Pro-Proteinen
ATE85077T1 (de) Enzym zur alpha-amidierung von c-termini und verfahren zu dessen herstellung.
IL112236A (en) Process for minimizing degradation of activated protein c
ATE277173T1 (de) Immobilisiertes enzym und verfahren zur herstellung von optisch aktiven cyanhydrinen
JPS6485996A (en) Peptide derivative and method for using said derivative
ATE237570T1 (de) Trennverfahren
AU1144699A (en) Group of nucleic acid molecules for (salmonella) detection, nucleic acids, kit and use